Literature DB >> 11337189

Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

J Black1, E S Moland, S A Chartrand, K S Thomson.   

Abstract

An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 microg/ml and was 8- to 16-fold more potent than levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337189     DOI: 10.1016/s0732-8893(01)00209-7

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.

Authors:  James A Karlowsky; Clyde Thornsberry; Ian A Critchley; Mark E Jones; Alan T Evangelista; Gary J Noel; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 2.  Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

Authors:  Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.